Literature DB >> 16750596

Puberty and polycystic ovary syndrome.

Selma Feldman Witchel1.   

Abstract

Polycystic ovary syndrome (PCOS) is a heterogeneous familial disorder characterized by chronic anovulation and hyperandrogenism. This multi-system, polygenic, multi-factorial disorder is associated with an increased risk for metabolic abnormalities such as type 2 diabetes mellitus. Signs and symptoms of PCOS often emerge during the peri-pubertal years with premature pubarche (PP) being the earliest manifestation for some girls. Insulin resistance and hyperinsulinemia are important pathophysiological features that are common to both PP and PCOS. Future investigations are needed to uncover the relevant genetic and hormonal factors and identify effective interventions.

Entities:  

Mesh:

Year:  2006        PMID: 16750596     DOI: 10.1016/j.mce.2006.04.028

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  21 in total

1.  Interventional studies for polycystic ovarian syndrome in children and adolescents.

Authors:  Patricia Myriam Vuguin
Journal:  Ped Health       Date:  2010-02

2.  Hyperandrogenemia in obese peripubertal girls: correlates and potential etiological determinants.

Authors:  Karen L Knudsen; Susan K Blank; Christine Burt Solorzano; James T Patrie; R Jeffrey Chang; Sonia Caprio; John C Marshall; Christopher R McCartney
Journal:  Obesity (Silver Spring)       Date:  2010-03-25       Impact factor: 5.002

Review 3.  [Polycystic ovary syndrome. Prototype of a cardio-metabolic syndrome].

Authors:  D Heutling; H Schulz; H Randeva; C Dodt; H Lehnert
Journal:  Internist (Berl)       Date:  2007-02       Impact factor: 0.743

Review 4.  Androgens and Blood Pressure Control: Sex Differences and Mechanisms.

Authors:  Jane F Reckelhoff
Journal:  Mayo Clin Proc       Date:  2019-01-31       Impact factor: 7.616

5.  Differential sleep-wake sensitivity of gonadotropin-releasing hormone secretion to progesterone inhibition in early pubertal girls.

Authors:  Jessicah S P Collins; John C Marshall; Christopher R McCartney
Journal:  Neuroendocrinology       Date:  2012-03-01       Impact factor: 4.914

6.  Body mass index at the presentation of premature adrenarche is associated with components of metabolic syndrome at puberty.

Authors:  Gamze Kaya; Zehra Yavas Abali; Firdevs Bas; Sukran Poyrazoglu; Feyza Darendeliler
Journal:  Eur J Pediatr       Date:  2018-07-28       Impact factor: 3.183

7.  Cardiovascular-renal and metabolic characterization of a rat model of polycystic ovary syndrome.

Authors:  Licy L Yanes; Damian G Romero; Mohaddetheh Moulana; Roberta Lima; Deborah D Davis; Huimin Zhang; Rachel Lockhart; Lorraine C Racusen; Jane F Reckelhoff
Journal:  Gend Med       Date:  2011-04

8.  Maturation of luteinizing hormone (gonadotropin-releasing hormone) secretion across puberty: evidence for altered regulation in obese peripubertal girls.

Authors:  Christopher R McCartney; Kathleen A Prendergast; Susan K Blank; Kristin D Helm; Sandhya Chhabra; John C Marshall
Journal:  J Clin Endocrinol Metab       Date:  2008-10-28       Impact factor: 5.958

9.  Pregnancy Protects Hyperandrogenemic Female Rats From Postmenopausal Hypertension.

Authors:  Noha M Shawky; Chetan N Patil; Carolina Dalmasso; Rodrigo O Maranon; Damian G Romero; Heather Drummond; Jane F Reckelhoff
Journal:  Hypertension       Date:  2020-08-03       Impact factor: 10.190

10.  Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome.

Authors:  Teresa Sir-Petermann; Ethel Codner; Virginia Pérez; Bárbara Echiburú; Manuel Maliqueo; Amanda Ladrón de Guevara; Jessica Preisler; Nicolás Crisosto; Fernando Sánchez; Fernando Cassorla; Shalender Bhasin
Journal:  J Clin Endocrinol Metab       Date:  2009-02-17       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.